Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 124

1.

Highly differentiated cytotoxic T cells in inclusion body myositis.

Greenberg SA, Pinkus JL, Kong SW, Baecher-Allan C, Amato AA, Dorfman DM.

Brain. 2019 Sep 1;142(9):2590-2604. doi: 10.1093/brain/awz207.

PMID:
31326977
2.

Cytotoxic KLRG1 expressing lymphocytes invade portal tracts in primary biliary cholangitis.

Li Y, Li B, You Z, Zhang J, Wei Y, Li Y, Chen Y, Huang B, Wang Q, Miao Q, Peng Y, Fang J, Gershwin ME, Tang R, Greenberg SA, Ma X.

J Autoimmun. 2019 Sep;103:102293. doi: 10.1016/j.jaut.2019.06.004. Epub 2019 Jun 27.

3.

Co-inhibitory T cell receptor KLRG1: human cancer expression and efficacy of neutralization in murine cancer models.

Greenberg SA, Kong SW, Thompson E, Gulla SV.

Oncotarget. 2019 Feb 15;10(14):1399-1406. doi: 10.18632/oncotarget.26659. eCollection 2019 Feb 15.

4.

Inclusion body myositis: clinical features and pathogenesis.

Greenberg SA.

Nat Rev Rheumatol. 2019 May;15(5):257-272. doi: 10.1038/s41584-019-0186-x. Review.

PMID:
30837708
5.

Provider Perspectives of Medication Complexity in Home Health Care: A Qualitative Secondary Data Analysis.

Squires A, Ridge L, Miner S, McDonald MV, Greenberg SA, Cortes T.

Med Care Res Rev. 2019 Feb 7:1077558719828942. doi: 10.1177/1077558719828942. [Epub ahead of print]

PMID:
30730237
6.

Five years of fecal microbiota transplantation - an update of the Israeli experience.

Greenberg SA, Youngster I, Cohen NA, Livovsky DM, Strahilevitz J, Israeli E, Melzer E, Paz K, Fliss-Isakov N, Maharshak N.

World J Gastroenterol. 2018 Dec 21;24(47):5403-5414. doi: 10.3748/wjg.v24.i47.5403.

7.

Camphor white oil induces tumor regression through cytotoxic T cell-dependent mechanisms.

Moayedi Y, Greenberg SA, Jenkins BA, Marshall KL, Dimitrov LV, Nelson AM, Owens DM, Lumpkin EA.

Mol Carcinog. 2019 May;58(5):722-734. doi: 10.1002/mc.22965. Epub 2019 Jan 20.

PMID:
30582219
8.

Reduced hospitalization rates are not associated with increased mortality or readmission rates in an emergency department in Israel.

Greenberg SA, Halpern P, Ziv-Baran T, Gamzu R.

Isr J Health Policy Res. 2018 Nov 20;7(1):69. doi: 10.1186/s13584-018-0265-5.

9.

Advances in Cutaneous Lupus Erythematosus and Dermatomyositis: A Report from the 4th International Conference on Cutaneous Lupus Erythematosus-An Ongoing Need for International Consensus and Collaborations.

Concha JSS, Patsatsi A, Marshak-Rothstein A, Liu ML, Sinha AA, Lee LA, Merola JF, Jabbari A, Gudjonsson JE, Chasset F, Jarrett P, Chong B, Arkin L, Fernandez AP, Caproni M, Greenberg SA, Kim HJ, Pearson DR, Femia A, Vleugels RA, Fiorentino D, Fujimoto M, Wenzel J, Werth VP.

J Invest Dermatol. 2019 Feb;139(2):270-276. doi: 10.1016/j.jid.2018.08.017. Epub 2018 Sep 19. No abstract available.

PMID:
30243657
10.

Health care costs and comorbidities for patients with inclusion body myositis.

Keshishian A, Greenberg SA, Agashivala N, Baser O, Johnson K.

Curr Med Res Opin. 2018 Sep;34(9):1679-1685. doi: 10.1080/03007995.2018.1486294. Epub 2018 Jul 5.

PMID:
29874942
11.

Geriatric Interdisciplinary Team Training 2.0: A collaborative team-based approach to delivering care.

Giuliante MM, Greenberg SA, McDonald MV, Squires A, Moore R, Cortes TA.

J Interprof Care. 2018 Sep;32(5):629-633. doi: 10.1080/13561820.2018.1457630. Epub 2018 Apr 6.

PMID:
29624089
12.

Diseases of the lips.

Greenberg SA, Schlosser BJ, Mirowski GW.

Clin Dermatol. 2017 Sep - Oct;35(5):e1-e14. doi: 10.1016/j.clindermatol.2017.11.003. Epub 2017 Nov 16. Review.

PMID:
29289276
13.

Validating the Health Literacy Promotion Practices Assessment Instrument.

Squires AP, Yin HS, Jones SA, Greenberg SA, Moore R, Cortes TA.

Health Lit Res Pract. 2017 Dec 11;1(4):e239-e246. doi: 10.3928/24748307-20171030-01. eCollection 2017 Oct.

14.

Unfounded Claims of Improved Functional Outcomes Attributed to Follistatin Gene Therapy in Inclusion Body Myositis.

Greenberg SA.

Mol Ther. 2017 Oct 4;25(10):2235-2237. doi: 10.1016/j.ymthe.2017.09.002. Epub 2017 Sep 8. No abstract available.

15.

A post-master's advanced certificate in gerontology for NPs.

Greenberg SA, Squires A, Adams J, Altshuler L, Oh SY, Blachman NL, Cortes TA.

Nurse Pract. 2017 Sep 21;42(9):18-23. doi: 10.1097/01.NPR.0000521992.53558.73.

PMID:
28787349
16.

Identifying distinct risk profiles to predict adverse events among community-dwelling older adults.

O'Connor M, Hanlon A, Mauer E, Meghani S, Masterson-Creber R, Marcantonio S, Coburn K, Van Cleave J, Davitt J, Riegel B, Bowles KH, Keim S, Greenberg SA, Sefcik JS, Topaz M, Kong D, Naylor M.

Geriatr Nurs. 2017 Nov - Dec;38(6):510-519. doi: 10.1016/j.gerinurse.2017.03.013. Epub 2017 May 4.

17.

Inclusion body myositis pathogenesis: Steady progress.

Greenberg SA.

Ann Neurol. 2017 Apr;81(4):498-501. doi: 10.1002/ana.24920. Epub 2017 Apr 3. No abstract available.

PMID:
28318035
18.

Inclusion Body Myositis.

Greenberg SA.

Continuum (Minneap Minn). 2016 Dec;22(6, Muscle and Neuromuscular Junction Disorders):1871-1888. Review.

PMID:
27922498
19.

Measuring fear of falling among high-risk, urban, community-dwelling older adults.

Greenberg SA, Sullivan-Marx E, Sommers ML, Chittams J, Cacchione PZ.

Geriatr Nurs. 2016 Nov - Dec;37(6):489-495. doi: 10.1016/j.gerinurse.2016.08.018. Epub 2016 Oct 5.

PMID:
27720210
20.

Correlation of cutaneous disease activity with type 1 interferon gene signature and interferon β in dermatomyositis.

Huard C, Gullà SV, Bennett DV, Coyle AJ, Vleugels RA, Greenberg SA.

Br J Dermatol. 2017 May;176(5):1224-1230. doi: 10.1111/bjd.15006. Epub 2017 Mar 14.

PMID:
27564228
21.

Association of inclusion body myositis with T cell large granular lymphocytic leukaemia.

Greenberg SA, Pinkus JL, Amato AA, Kristensen T, Dorfman DM.

Brain. 2016 May;139(Pt 5):1348-60. doi: 10.1093/brain/aww024. Epub 2016 Feb 26.

PMID:
26920676
22.

Anti- C N1A antibodies in South Australian patients with inclusion body myositis.

Limaye VS, Lester S, Blumbergs P, Greenberg SA.

Muscle Nerve. 2016 Apr;53(4):654-5. doi: 10.1002/mus.24989. No abstract available.

PMID:
26599102
23.

INPP4B overexpression is associated with poor clinical outcome and therapy resistance in acute myeloid leukemia.

Dzneladze I, He R, Woolley JF, Son MH, Sharobim MH, Greenberg SA, Gabra M, Langlois C, Rashid A, Hakem A, Ibrahimova N, Arruda A, Löwenberg B, Valk PJ, Minden MD, Salmena L.

Leukemia. 2015 Jul;29(7):1485-95. doi: 10.1038/leu.2015.51. Epub 2015 Mar 4.

PMID:
25736236
24.

Treatment of sporadic inclusion body myositis with bimagrumab.

Amato AA, Sivakumar K, Goyal N, David WS, Salajegheh M, Praestgaard J, Lach-Trifilieff E, Trendelenburg AU, Laurent D, Glass DJ, Roubenoff R, Tseng BS, Greenberg SA.

Neurology. 2014 Dec 9;83(24):2239-46. doi: 10.1212/WNL.0000000000001070. Epub 2014 Nov 7.

25.

Severe motor neuropathy or neuronopathy due to nitrous oxide toxicity after correction of vitamin B12 deficiency.

Morris N, Lynch K, Greenberg SA.

Muscle Nerve. 2015 Apr;51(4):614-6. doi: 10.1002/mus.24482. Epub 2015 Feb 24.

PMID:
25297001
26.

Myasthenis gravis or Lambert-Eaton myasthenic syndrome?

Dineen JM, Greenberg SA.

Am J Phys Med Rehabil. 2015 Feb;94(2):e20-1. doi: 10.1097/PHM.0000000000000176. No abstract available.

PMID:
25133625
27.

Evaluation and construction of diagnostic criteria for inclusion body myositis.

Lloyd TE, Mammen AL, Amato AA, Weiss MD, Needham M, Greenberg SA.

Neurology. 2014 Jul 29;83(5):426-33. doi: 10.1212/WNL.0000000000000642. Epub 2014 Jun 27. Review.

28.

Inclusion body myositis and chronic lymphocytic leukemia: a case series.

Beck EH, Amato AA, Greenberg SA.

Neurology. 2014 Jul 1;83(1):98-9. doi: 10.1212/WNL.0000000000000546. Epub 2014 May 23. No abstract available.

29.

Abnormal distribution of heterogeneous nuclear ribonucleoproteins in sporadic inclusion body myositis.

Pinkus JL, Amato AA, Taylor JP, Greenberg SA.

Neuromuscul Disord. 2014 Jul;24(7):611-6. doi: 10.1016/j.nmd.2014.04.012. Epub 2014 May 6.

PMID:
24857366
30.

What role for ultrasound in diagnosing carpal tunnel syndrome?

Dineen JM, Greenberg SA.

Pract Neurol. 2014 Oct;14(5):286-7. doi: 10.1136/practneurol-2014-000833. Epub 2014 May 14. No abstract available.

PMID:
24828682
31.

Pseudochoreoathetosis in sensory ataxic variant of Guillain-Barré syndrome.

Dineen JM, Greenberg SA.

Muscle Nerve. 2014 Aug;50(2):300-1. doi: 10.1002/mus.24278. No abstract available.

PMID:
24801448
32.

Inhibition of myogenic microRNAs 1, 133, and 206 by inflammatory cytokines links inflammation and muscle degeneration in adult inflammatory myopathies.

Georgantas RW, Streicher K, Greenberg SA, Greenlees LM, Zhu W, Brohawn PZ, Higgs BW, Czapiga M, Morehouse CA, Amato A, Richman L, Jallal B, Yao Y, Ranade K.

Arthritis Rheumatol. 2014 Apr;66(4):1022-33. doi: 10.1002/art.38292.

33.

Cytoplasmic 5'-nucleotidase autoantibodies in inclusion body myositis: Isotypes and diagnostic utility.

Greenberg SA.

Muscle Nerve. 2014 Oct;50(4):488-92. doi: 10.1002/mus.24199.

PMID:
24752512
34.

Resection of an upper cervical aneurysmal bone cyst and spinal reconstruction using a midline mandibular osteotomy in a pediatric patient.

McDowell MM, Hanft SJ, Greenberg SA, Rahmati R, Carrao V, Eisig S, Anderson RC.

J Neurosurg Pediatr. 2014 Jun;13(6):622-5. doi: 10.3171/2014.3.PEDS13511. Epub 2014 Apr 4.

PMID:
24702619
35.

Sustained autoimmune mechanisms in dermatomyositis.

Greenberg SA.

J Pathol. 2014 Jul;233(3):215-6. doi: 10.1002/path.4355.

PMID:
24687932
36.

The plasma cell signature in autoimmune disease.

Streicher K, Morehouse CA, Groves CJ, Rajan B, Pilataxi F, Lehmann KP, Brohawn PZ, Higgs BW, McKeever K, Greenberg SA, Fiorentino D, Richman LK, Jallal B, Herbst R, Yao Y, Ranade K.

Arthritis Rheumatol. 2014 Jan;66(1):173-84. doi: 10.1002/art.38194.

37.

Inflammatory myopathies.

Amato AA, Greenberg SA.

Continuum (Minneap Minn). 2013 Dec;19(6 Muscle Disease):1615-33. doi: 10.1212/01.CON.0000440662.26427.bd. Review.

PMID:
24305450
38.

Biomarkers of inclusion body myositis.

Greenberg SA.

Curr Opin Rheumatol. 2013 Nov;25(6):753-62. doi: 10.1097/01.bor.0000434665.75998.f5. Review.

PMID:
24067380
39.

Type 1 interferons inhibit myotube formation independently of upregulation of interferon-stimulated gene 15.

Franzi S, Salajegheh M, Nazareno R, Greenberg SA.

PLoS One. 2013 Jun 4;8(6):e65362. doi: 10.1371/journal.pone.0065362. Print 2013.

40.

Cytosolic 5'-nucleotidase 1A autoimmunity in sporadic inclusion body myositis.

Larman HB, Salajegheh M, Nazareno R, Lam T, Sauld J, Steen H, Kong SW, Pinkus JL, Amato AA, Elledge SJ, Greenberg SA.

Ann Neurol. 2013 Mar;73(3):408-18. doi: 10.1002/ana.23840.

PMID:
23596012
41.

Teaching NeuroImages: differential diagnosis of scapular winging.

Amato AA, Greenberg SA.

Neurology. 2013 Jan 22;80(4):420. No abstract available.

PMID:
23469369
42.

Mutations in prion-like domains in hnRNPA2B1 and hnRNPA1 cause multisystem proteinopathy and ALS.

Kim HJ, Kim NC, Wang YD, Scarborough EA, Moore J, Diaz Z, MacLea KS, Freibaum B, Li S, Molliex A, Kanagaraj AP, Carter R, Boylan KB, Wojtas AM, Rademakers R, Pinkus JL, Greenberg SA, Trojanowski JQ, Traynor BJ, Smith BN, Topp S, Gkazi AS, Miller J, Shaw CE, Kottlors M, Kirschner J, Pestronk A, Li YR, Ford AF, Gitler AD, Benatar M, King OD, Kimonis VE, Ross ED, Weihl CC, Shorter J, Taylor JP.

Nature. 2013 Mar 28;495(7442):467-73. doi: 10.1038/nature11922. Epub 2013 Mar 3.

43.

A phase 1b clinical trial evaluating sifalimumab, an anti-IFN-α monoclonal antibody, shows target neutralisation of a type I IFN signature in blood of dermatomyositis and polymyositis patients.

Higgs BW, Zhu W, Morehouse C, White WI, Brohawn P, Guo X, Rebelatto M, Le C, Amato A, Fiorentino D, Greenberg SA, Drappa J, Richman L, Greth W, Jallal B, Yao Y.

Ann Rheum Dis. 2014 Jan;73(1):256-62. doi: 10.1136/annrheumdis-2012-202794. Epub 2013 Feb 23.

44.

Genomic signatures characterize leukocyte infiltration in myositis muscles.

Zhu W, Streicher K, Shen N, Higgs BW, Morehouse C, Greenlees L, Amato AA, Ranade K, Richman L, Fiorentino D, Jallal B, Greenberg SA, Yao Y.

BMC Med Genomics. 2012 Nov 21;5:53. doi: 10.1186/1755-8794-5-53.

45.

Pathogenesis and therapy of inclusion body myositis.

Greenberg SA.

Curr Opin Neurol. 2012 Oct;25(5):630-9. doi: 10.1097/WCO.0b013e328357f211. Review.

PMID:
22941263
46.

Risk of Guillain-Barré syndrome after meningococcal conjugate vaccination.

Velentgas P, Amato AA, Bohn RL, Chan KA, Cochrane T, Funch DP, Dashevsky I, Duddy AL, Gladowski P, Greenberg SA, Kramer JM, McMahill-Walraven C, Nakasato C, Spettell CM, Syat BL, Wahl PM, Walker AM, Zhang F, Brown JS, Platt R.

Pharmacoepidemiol Drug Saf. 2012 Dec;21(12):1350-8. doi: 10.1002/pds.3321. Epub 2012 Jul 16.

PMID:
22807266
47.

Multiple sclerosis-linked and interferon-beta-regulated gene expression in plasmacytoid dendritic cells.

Aung LL, Brooks A, Greenberg SA, Rosenberg ML, Dhib-Jalbut S, Balashov KE.

J Neuroimmunol. 2012 Sep 15;250(1-2):99-105. doi: 10.1016/j.jneuroim.2012.05.013. Epub 2012 Jun 9.

48.

Myofasciitis: imaging and pathology.

Greenberg SA, Amato AA.

Arch Neurol. 2012 Mar;69(3):406. doi: 10.1001/archneurol.2011.1159. No abstract available.

PMID:
22410452
49.

Analysis of measurement tools of fear of falling for high-risk, community-dwelling older adults.

Greenberg SA.

Clin Nurs Res. 2012 Feb;21(1):113-30. doi: 10.1177/1054773811433824. Review.

PMID:
22373731
50.

Metastatic renal cell carcinoma with radiologic appearance of a meningioma.

Jadhav AP, Greenberg SA.

Arch Neurol. 2012 Jun;69(6):780-1. doi: 10.1001/archneurol.2011.500. No abstract available.

PMID:
22332182

Supplemental Content

Loading ...
Support Center